Newly Released Pfizer Documents Reveal COVID Jab Dangers

In September 2021, a group called Public Health and Medical Professionals for Transparency (PHMPT) filed a Freedom of Information Act (FOIA) request with the U.S. Food and Drug Administration to obtain the documentation used to approve Comirnaty, including safety and effectiveness data, adverse reaction reports and lists of active and inactive ingredients.

When, after a month, the FDA still had not responded to the FOIA request, the PHMPT sued.¹ Pfizer and the FDA asked the judge to give them 75 years to release all the documents (doling out just 500 pages per month)² but, fortunately, the judge ruled that they have to release them at a rate of 55,000 pages per month.

COVID Jab Supporter Gets Red-Pilled

In mid-November 2021, the FDA released the first 91 pages,^3,4 which alone revealed the FDA has been aware of shocking safety issues since April 30, 2021. For nurse educator John Campbell, featured in the video above, these documents appear to have served as a “red pill,”⁵ waking him up to the possibility that the jabs may be far more dangerous than anyone expected, but he didn’t get around to reviewing them until now.

In his video, Campbell reviews the documents listed as “5.3.6. Postmarketing Experience,” which were originally marked “confidential.” They reveal that, cumulatively, through February 28, 2021, Pfizer received 42,086 adverse event reports, including 1,223 deaths.

As noted by Campbell, “It would have been good to know about this at the time, wouldn’t it?” referring to the rollout of the jabs. Campbell has been fairly consistent in his support of the “safe and effective” vaccine narrative, but “This has just destroyed trust in authority,” he says.

To have 1,223 fatalities and 42,086 reports of injury in the first three months is a significant safety signal, especially when you consider that the 1976 swine flu vaccine was pulled after only 25 deaths.

Now, the number of doses shipped has been redacted under a FOIA redaction code that stands for “Trade secrets and commercial or financial information obtained from a person and privileged or confidential.” Why would the number of doses shipped be confidential?

Campbell is clearly bothered by this redaction, as you cannot calculate the incidence rate or side effects if you don’t know what the denominator is. As noted by Campbell, that number cannot be proprietary. It’s being withheld for some other reason (and I just stated what that might be).

Even without knowing the underreporting factor, Campbell is appalled by the number of reported side effects. It is very clear that this information red-pilled Campbell. For an overview of the types of side effects recorded, check out Campbell’s video. I’ve already reviewed that in previous articles.

Here, we’ll move on to the first really large tranche of Pfizer documents, which was released March 1, 2022. In all, the FDA has some 450,000 pages of data from Pfizer’s COVID jab trials, and we now have just over 10,000 of those pages. You can find them all on PHMPT.org.⁶

Findings From Early Review of Case Reports

March 7, 2022, investigative journalist Sonia Elijah published a review of her initial findings on Trial Site News,⁷ having glossed through some of the thousands of newly-released documents.

Her review centers primarily on the case report forms (CRFs). These are documents used in clinical research to record standardized data from each patient, including adverse events. As such, they’re a crucial part of the clinical trial process.

A majority of the CRFs in this release were from Ventavia-run trial sites. Ventavia is currently facing a lawsuit brought by Brook Jackson, a former Ventavia regional director. Jackson was fired shortly after she brought concerns about potential data falsification and poor laboratory management to the attention of the FDA and higher-ups in the company.

Her testimony was published November 2, 2021, in The British Medical Journal — the oldest and most prestigious medical journal in the world — by investigative journalist Paul Thacker.⁸ Facebook fact checkers actually tried to “debunk” this BMJ article and censored it.

In her review of the CRFs, Elijah found a number of errors and anomalies that seem to corroborate Jackson’s claims, including the following:⁹

• Patients entered into the “healthy population” group who were far from healthy — For example, one such “healthy” participant was a Type 2 diabetic with angina, a cardiac stent and a history of heart attack.
• Serious adverse event (SAE) numbers were left blank — Ventavia site No. 1085 has a particularly large number of missing SAE numbers.
• Missing barcodes for samples collected — Without those barcodes, you can’t match the sample to the participant.
• Suspicious-looking SAE start and end dates — For example, the so-called “healthy” diabetic suffered a “serious” heart attack October 27, 2020. The “end” date is listed as October 28, the next day, which is odd because it was recorded as serious enough to require hospitalization.

Also, on that same day, October 28, the patient was diagnosed with pneumonia, so likely remained hospitalized. “This anomaly raises doubt as to the accuracy of these recorded dates, potentially violating ALOCA-C clinical site documentation guidelines for clinical trials,” Elijah writes.

• Unblinded teams were responsible for reviewing adverse event reports for signs of COVID cases, and to review severe COVID cases — Yet in some cases they appear to have dismissed the possibility of an event being COVID-related, such as pneumonia. This despite the fact that Pfizer’s protocol (section 8.2.4) lists “enhanced COVID-19” (i.e., antibody dependent enhancement) as a potential side effect to be on the lookout for. As noted by Elijah:

“Inadvertently, this could have led to bias, as the unblinded teams would have been aware which participants were assigned the placebo and those who received the vaccine. They might have been under pressure by the sponsor for the trial to go a certain way and for events like ‘COVID Pneumonia’ to be classified simply as pneumonia.”

• Impossible dating — The diabetic who suffered a heart attack followed by pneumonia (which may have been unacknowledged COVID pneumonia) died, and the date of death is listed as the day before the patient supposedly went for a “COVID ill” visit.

Clearly, it’s impossible for a dead person to attend a medical visit, so something is wrong here. The clinical investigator note states: “There cannot be a date later than date of death. Please remove data from the COVID illness visit and add cough and shortness of breath as AEs (adverse events).” “What kind of pressure was being exerted here?” Elijah asks.

• Adverse events listed as “not serious” despite extended hospital stay — In one case, the participant fell and suffered facial lacerations the day after the second dose and was hospitalized for 26 days, yet the fall was not reported as serious.

Other anomalies in this particular case include listing the fall as being caused by a “fall” unrelated to the study treatment, and the facial laceration being the result of “hypotension” (low blood pressure). The SAE number is also missing for the facial lacerations.

Elijah writes, “Doubts can be raised over the credibility of this information given the fall and facial lacerations were intrinsically related. So, if facial lacerations were due to ‘hypotension’ then the fall should be due to that too.” Might low blood pressure be an effect of the experimental shot? Possibly. Especially when you consider the patient fell the day after being given the second dose.

Even more suspicious: the causality for the fall was recorded as “related” (to the treatment) on the serious adverse event form, but listed as “not related” on the adverse event CRF. A note states, “Please confirm correct causality.”

• Dismissing brand new health problems as unrelated to the treatment — For example, in one case, a female participant with no medical history of impaired kidney function was diagnosed with kidney stones and severe hypokalemia, requiring hospitalization, one month after her second dose. Yet despite her having no history of kidney problems, both events were dismissed as “not related” to the study treatment and no further investigation was done.

In closing, Elijah writes:¹⁰

“All the evidence gleaned over a limited time appears to back up whistleblower Jackson’s claims of poor trial site data management and raises questions as to how Ventavia conducted the Pfizer clinical trials.

The errors and anomalies in the CRFs also allude to her claims that the clinical research associates were not trained adequately, with many having had no prior clinical experience history. If such egregious findings are true at these sites, could they manifest at other trial sites around North America and beyond?”

Enormous List of Side Effects

The latest tranche of Pfizer documents also includes a whopping nine pages of recorded side effects — 158,000 in all! The picture below speaks louder than anything I can say about this list. (see source)

Views expressed in this article are the opinions of the author and do not necessarily reflect the views of NTD Canada.